FRANK KARBE - 24 Feb 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Chief Financial Officer
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 24 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 26 Feb 2025, 18:31:07 UTC
Previous filing: 16 Dec 2024
Next filing: 05 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+57,500		$0.000000	57,500	24 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+115,000		$0.000000	115,000	24 Feb 2025	Common Stock	115,000	$20.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on February 24, 2025. All RSUs vest in four equal annual installments, with 1/4 vesting on each of March 10, 2026, 2027, 2028, and 2029, subject to continuous service through each such vesting date.
F2	25% of the shares subject to the option shall vest on the 1st anniversary of the vesting commencement date of February 24, 2025, and the balance of the shares shall vest in a series of 36 equal monthly installments measured from the 1st anniversary of the vesting commencement date, such that the option will be fully vested on February 24, 2029, subject to continuous service through each such vesting date.

Content

Represents time-based Restricted Stock Units (RSUs) granted on February 24, 2025. All RSUs vest in four equal annual installments, with 1/4 vesting on each of March 10, 2026, 2027, 2028, and 2029, subject to continuous service through each such vesting date.

25% of the shares subject to the option shall vest on the 1st anniversary of the vesting commencement date of February 24, 2025, and the balance of the shares shall vest in a series of 36 equal monthly installments measured from the 1st anniversary of the vesting commencement date, such that the option will be fully vested on February 24, 2029, subject to continuous service through each such vesting date.